SLRX - Salarius Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.1 0.41 (10.0%)	---	0.0 (0.0%)	0.01 (0.22%)	0.17 (4.15%)	0.46 (11.06%)	-0.09 (-1.96%)	-0.09 (-1.96%)

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.45
Diluted EPS:: -0.45
Basic P/E:: -10.0222
Diluted P/E:: -10.0222
RSI(14) 1m:: 100.0
VWAP:: 4.51
RVol:: 0.7649

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.64 +0.12 (+2.65%)	Oct 15 15:56
1m	Price decrease 1m	4.46 -0.06 (-1.33%)	Oct 15 15:52
1m	Price increase 1m	4.55 +0.16 (+3.64%)	Oct 15 15:49
60m	Price increase 60m	4.55 +0.25 (+5.81%)	Oct 15 15:49
10m	Price increase 10m	4.55 +0.24 (+5.57%)	Oct 15 15:49